2 |
Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression
|
|
|
|
BASE
|
|
Show details
|
|
3 |
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
|
|
|
|
BASE
|
|
Show details
|
|
4 |
Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategy
|
|
|
|
BASE
|
|
Show details
|
|
5 |
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
|
|
|
|
BASE
|
|
Show details
|
|
6 |
Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression
|
|
|
|
BASE
|
|
Show details
|
|
7 |
Mortality and prognostic factors in Spanish patients with systemic sclerosis
|
|
|
|
BASE
|
|
Show details
|
|
8 |
Pericardial tamponade preceding cutaneous involvement in systemic sclerosis.
|
|
|
|
BASE
|
|
Show details
|
|
9 |
Pericardial tamponade preceding cutaneous involvement in systemic sclerosis.
|
|
|
|
BASE
|
|
Show details
|
|
|
|